Visionary Holdings Inc. said its wholly owned subsidiary, Visionary Health Technology Group Limited (GV Hong Kong), is continuing execution of a previously signed commercial sales agreement valued at approximately US$9 million. The company said the agreement, signed in September 2025, remains in the implementation stage with early-stage service activities underway, and it expects further substantive execution milestones by the end of the first quarter of 2026. Visionary said revenue recognition and cash collection will be recorded in accordance with the contract terms and applicable accounting standards, and the agreement covers the Premier Regenerative Complex product series and customized VIP health services.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Visionary Holdings Inc published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202602240950PRIMZONEFULLFEED9660144) on February 24, 2026, and is solely responsible for the information contained therein.
Comments